Intravenous morphine for emergency treatment of cancer pain

Abstract

Despite the wide use of the World Health Organization (WHO) analgesic ladder for the relief of cancer pain, it is not uncommon to find patients presenting with severe pain to palliative care centres. This is more so in the developing world, where facilities for pain relief are few and the health care system is not well organized. It has been the practice in a pain and palliative care clinic in south India to give repeated boluses of 1.5 mg of morphine intravenously every 10 min to patients presenting with severe pain. An audit of the procedure was undertaken by a retrospective study of 793 case notes. Seventy-nine per cent of patients had total relief of their pain with intravenous morphine. Three per cent of patients experienced side-effects during the procedure. These included nausea and vomiting, itching, giddiness, restlessness, dyspnoea, chest pain, disorientation and a feeling of uneasiness. Thirty-two per cent of patients had drowsiness, which was one of the end-points of the procedure. It is concluded that intravenous morphine in repeated boluses of 1.5 mg every 10 min is a safe and effective method of managing cancer pain emergencies in a clinical setting in a developing country.

Keywords

administration,intravenous analgesia developing countries morphine neoplasms pain palliative care

Get full access to this article

View all access options for this article.

References

Portenoy RK . Cancer pain: epidemiology and symptoms. Cancer 1989; 63: 2298–2307.

Foley K . The treatment of cancer pain. N Engl J Med 1985; 313: 84–95.

Ventafridda V , Caraceni A , Gamba A . Field testing of the WHO Guidelines for Cancer Pain Relief: summary report of demonstration projects. In: Foley KM , Bonica JJ , Ventafridda V eds. Proceedings of the Second International Congress on Pain. Vol 16, Advances in pain research and therapy. New York: Raven Press, 1990: 155–165.

Suresh Kumar K , Rajagopal MR . Palliative care in Kerala: problems at presentation in 440 patients with advanced cancer in a South Indian state. Palliat Med 1996; 10: 293–298.

Hagen NA , Elwood T , Ernst S . Cancer pain emergencies: a protocol for management. J Pain Symptom Manage 1997; 14: 45–49.

Aitkenhead AR , Vater M , Achola K , Cooper CM , Smith G . Pharmacokinetics of single dose IV morphine in normal volunteers and patients with end-stage renal failure. Br J Anaesth 1984; 56: 813–819.

Hug CC Jr , Murphy MR , Rigel EP , Olson WA . Pharmacokinetics of morphine injected intravenously into the anaesthetized dog. Anaesthesiology 1981; 54: 38.

Dahlstrom BE , Paalzow LK . Pharmacokinetic interpretation of the enterohepatic recirculation and first-pass elimination of morphine in the rat. J Phamacokin Biopharm 1978; 6: 505.

Whitehead EM , O'Sullivan GM , Lloyd J , Bullingham RE . A new method for rate of analgesic onset: two doses of intravenous morphine compared with placebo. Clin Phamacol Ther 1992; 52: 197–204.

10.

Cleeland CS et al. Culture, language, and cancer pain. In: Jensen, Turner Wiesenfield-Hallin eds. Proceedings of the Eight World Congress on Pain. Seattle: IASP Press, 1997: 47.